Sofosbuvir plus ribavirin combination regimen boost liver functions and antioxidant profile in hepatitis C virus

Omayma A Ragab AboZaid1, Mohamed K Mahfouz1, Omneia M Abdel Hammed1

  • 1Department of Biochemistry, Benha University, Egypt.

Microbial Pathogenesis
|January 18, 2021
PubMed

Insights

Treatment with Sofosbuvir and Ribavirin significantly improved liver function and antioxidant profiles in Hepatitis C virus patients. This combination therapy offers a promising approach for managing liver damage caused by the Hepatitis C virus.

Area of Science:

  • Hepatology
  • Virology
  • Biochemistry

Background:

  • Hepatitis C virus (HCV) infection is a major global health concern, causing significant liver damage and contributing to morbidity and mortality.
  • Effective antiviral therapies are crucial for managing HCV and preventing its long-term consequences.

Purpose of the Study:

  • To evaluate the impact of combined Sofosbuvir and Ribavirin therapy on liver function and antioxidant status in patients with Hepatitis C virus infection.

Main Methods:

  • A study involving 30 Hepatitis C virus patients and 10 healthy volunteers was conducted.
  • Liver function tests and antioxidant profiles were assessed before and after treatment with Sofosbuvir and Ribavirin.

Main Results:

  • Treatment led to a significant decrease in elevated liver enzymes (ALT, AST, ALP), bilirubin, and AFP.
  • Significant improvements were observed in antioxidant enzyme activities, including glutathione peroxidase, catalase, and superoxide dismutase.
  • Levels of L-Malondialdhyde, albumin, and total protein also showed significant changes indicating improved liver health.

Conclusions:

  • Combination therapy with Sofosbuvir and Ribavirin effectively improves liver function parameters in Hepatitis C virus patients.
  • This treatment regimen also enhances the body's antioxidant defense system, mitigating oxidative stress associated with HCV infection.

Related Concept Videos

Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.9K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.6K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
48.4K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
81
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
81
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
356